Research progress of the local treatments on choroidal metastasis of lung cancer

doi:10.3969/j.issn.1674-8115.2018.02.022

›› 2018, Vol. 38 ›› Issue (2): 233-.doi: 10.3969/j.issn.1674-8115.2018.02.022

• Review • Previous Articles Next Articles

Research progress of the local treatments on choroidal metastasis of lung cancer

YU Huan1 , LI Qing-yun2

1. Department of Ophthalmology, 2. Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Online:2018-02-28 Published:2018-03-09
Supported by:
Shanghai Key Discipline for Respiratory Diseases, 2017ZZ02014

Abstract

Abstract: The choroid is one of the most common ocular sites for metastatic disease. Lung cancer is the first cause of choroidal metastasis among primary cancers in China. The current management of choroidal metastasis of lung cancer is based on the combination of systemic treatments and local treatments. The latter mainly include radiotherapy, transpupillary thermotherapy, photodynamic therapy, intravitreous injection and enucleation. This review covers the research progress in local treatments on choroidal metastasis of lung cancer.

Key words: choroidal metastases, lung cancer, local treatment

YU Huan1,LI Qing-yun2. Research progress of the local treatments on choroidal metastasis of lung cancer[J]. , 2018, 38(2): 233-.

[1]	Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU. Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748.
[2]	Jian-hua XU, Ping JIANG, Jiong DENG. Expression and significance of ATP-binding cassette superfamily G member 2 in lung cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 830-833.
[3]	XU Shu-lin, WU Jing, LOU Jia-tao. Correlation analysis of lung cancer and anemia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1500-1504.
[4]	HE Chun-ming, YIN Hang, TANG Jian, DING Yi-zong, FU Yu-jie, ZHAO Xiao-jing. Establishment and internal validation of a prognostic model for elderly patients after lung cancer surgery based on SEER [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1554-1561.
[5]	ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao. Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors [J]. , 2020, 40(1): 37-.
[6]	ZOU Chen1, 2, XU Run-hao1, 3, ZHANG Hong2, MA Zhan2, CHEN Li2, ZHANG Jie3, LI Min3, ZHANG Shu-lin1. Potential roles of small metabolites in the differential diagnosis between lung cancer and pneumonia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1041-1047.
[7]	HE Chun-ming, YIN Hang, ZHENG Jia-jie, TANG Jian, FU Yu-jie, ZHAO Xiao-jing. Immunotherapy for lung cancer: immunosuppressive cells and intrapulmonary immunity [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1137-1142.
[8]	QU Guo-jun1, LU Yuan-feng2, LI Yu1. Mechanism of CCT2, a new downstream substrate of PDGFRα, on proliferation of tumor cells [J]. , 2019, 39(1): 28-.
[9]	HE Ya-ping1, LOU Wei-qun2, CHEN Jie-ling2, ZHOU Zhen3, ZHU Jing-fen1, JIAN Hong3. Influencing factors for quality of life in patients over 12 months after diagnosis of non-small cell lung cancer [J]. , 2018, 38(7): 775-.
[10]	DAI Wei, WANG Xiao-wen, HUANG Chun, XIANG Xiao-yong, JIANG Yin-jiu, WU Qing-chen. Research progress in the risk factors and mechanisms of postoperative atrial fibrillation after lung cancer surgery [J]. , 2018, 38(5): 573-.
[11]	ZHANG Li-yan, TAN Xiao-ming. Application in diagnosis and treatment of circulating tumor cell detection in lung cancer#br# [J]. , 2018, 38(3): 343-.
[12]	WANG Ye, XIE Wang, ZHANG Jie, SHENG Jie-ying, GUO Zhong-liang. Mechanism of hsa-miRNA124-3p regulating the proliferation and migration of human lung cancer cell line NCI-H460#br# [J]. , 2017, 37(8): 1051-.
[13]	HU Zhang-guo, CAO Shu-hui, ZHONG Hua . Efficacy of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR 21L861Q mutation#br# [J]. , 2017, 37(11): 1524-.
[14]	WAN Jian-wei, ZHOU Lin, ZHAO Dan-dan, YANG Yu-qin, LU Li-ming. Effects of PHPO on apoptosis and proliferation of lung cancer cell line A549#br# [J]. , 2017, 37(10): 1315-.
[15]	CHEN Lei, XIA Shu-yue. Therapeutic effect and safety of bevacizumab combined with cisplatin on malignant pleural effusion of patients with non-small cell lung cancer [J]. , 2015, 35(8): 1194-.

Research progress of the local treatments on choroidal metastasis of lung cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments